Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder.

MLA

Ashaat, Engy A., et al. “Sialic Acid and Anti-Ganglioside M1 Antibodies Are Invaluable Biomarkers Correlated with the Severity of Autism Spectrum Disorder.” Brain & Development, vol. 45, no. 4, Apr. 2023, pp. 212–19. EBSCOhost, https://doi.org/10.1016/j.braindev.2022.11.006.

APA

Ashaat, E. A., Sabry, S., Zaki, M. E., Mohamed, R., Abdelsattar, H. A., Bawady, S. A., Ashaat, N. A., Elnaggar, W., Ganem, M. M. F., El-Hariri, H. M., El-Bassyouni, H. T., & Saleh, D. A. (2023). Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder. Brain & Development, 45(4), 212–219. https://doi.org/10.1016/j.braindev.2022.11.006

Chicago

Ashaat, Engy A, Sahar Sabry, Moushira E Zaki, Ramy Mohamed, Hoda A Abdelsattar, Somia A Bawady, Neveen A Ashaat, et al. 2023. “Sialic Acid and Anti-Ganglioside M1 Antibodies Are Invaluable Biomarkers Correlated with the Severity of Autism Spectrum Disorder.” Brain & Development 45 (4): 212–19. doi:10.1016/j.braindev.2022.11.006.